Compounds > glycerophosphoinositol 4,5-bisphosphate
Page last updated: 2024-09-03

glycerophosphoinositol 4,5-bisphosphate and Long QT Syndrome 1

glycerophosphoinositol 4,5-bisphosphate has been researched along with Long QT Syndrome 1 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grushko, MJ; Liu, Z; McDonald, TV; Uversky, VN; Zheng, R1

Other Studies

1 other study(ies) available for glycerophosphoinositol 4,5-bisphosphate and Long QT Syndrome 1

ArticleYear
Functionally Aberrant Mutant KCNQ1 With Intermediate Heterozygous and Homozygous Phenotypes.
    The Canadian journal of cardiology, 2018, Volume: 34, Issue:9

    Topics: Biotinylation; Heterozygote; Homozygote; Humans; Immunoprecipitation; KCNQ1 Potassium Channel; Microscopy, Confocal; Mutation; Phosphatidylinositol 4,5-Diphosphate; Romano-Ward Syndrome; Severity of Illness Index

2018